Novo Nordisk on Monday said it will invest $4.1 billion in a new Clayton, N.C., manufacturing facility as it works to meet surging demand for its popular injectable drugs Wegovy and Ozempic.
[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
